The salvage liver transplantation (LT) strategy was conceived for initially resectable and transplantable hepatocellular carcinoma (HCC) to obviate upfront transplantation, with salvage LT in the case of recurrence. The longterm outcomes of a second resection for recurrent HCC have improved. The aim of this study was to perform an intention-to-treat analysis of overall survival (OS) comparing these 2 strategies for initially resectable and transplantable recurrent HCC. From 1994 to 2011, 391 patients with HCC who underwent salvage LT (n 5 77) or a second resection (n 5 314) were analyzed. Of 77 patients in the salvage LT group, 21 presented with resectable and transplantable recurrent HCC and 18 underwent transplantation. Of 314 patients in the second resection group, 81 presented with resectable and transplantable recurrent HCC and 81 underwent a second resection. The 5-year intention-to-treat OS rates, calculated from the time of primary hepatectomy, were comparable between the 2 strategies (72% for salvage transplantation versus 77% for second resection; P 5 0.57). In patients who completed the salvage LT or second resection procedure, the 5-year OS rates, calculated from the time of the second surgery, were comparable between the 2 strategies (71% versus 71%; P 5 0.99). The 5-year diseasefree survival (DFS) rates were 72% following transplantation and 18% following the second resection (P < 0.001). Similar results were observed after propensity score matching. In conclusion, although the 5-year OS rates were similar in the salvage LT and second resection groups, the salvage LT strategy still achieves better DFS. Second resection for recurrent HCC might be considered to be the best alternative option to LT in the current organ shortage.
Liver transplantation (LT) is the best treatment for hepatocellular carcinoma (HCC) in patients with cirrhosis fulfilling acknowledged criteria.
(1) The salvage LT strategy consists of primary liver resection with curative intent in patients with initially both resectable and transplantable HCC, followed by salvage LT in the case of transplantable tumor recurrence. (2, 3) This strategy could alleviate both the shortage of liver grafts and the wait-list dropout rate. With the salvage LT strategy, the transplantability rate of recurrence ranges from 3% (3) to 45%, (4) the post-LT mortality rate ranges from 0% to 13%, and the 5-year overall survival (OS) rate following transplant ranges from 41% (5) to 89%. (6) Moreover, both the indications for and outcomes of second resection for tumor recurrence have dramatically improved over the last 15 years. (7) A resectability rate of recurrence of 9% (8) to 30% (9) has been reported, with a postoperative mortality rate ranging from 0% in most series (7) to 6% (10) and a 5-year OS rate of 22% (11) to 83%. (12) Put into perspective, these results raise the question if second resection for resectable and transplantable recurrent HCC could achieve similar outcomes as salvage LT and inherently further improve the potential graft economy in the current era of severe organ shortage. The question is, so to speak, whether a second hepatectomy as part of a "reloaded" salvage LT strategy could be considered in the case of resectable and transplantable recurrence after this strategy was applied a first time. This novel question was the impetus for the present retrospective analysis of a large series of consecutive patients from 2 centers: 1 applying the salvage LT strategy and the other applying the second resection strategy. The aim of this study was to define the optimal curative option (transplantation or second resection) in patients with resectable and transplantable HCC by analyzing their longterm outcomes.
Patients and Methods
The salvage LT group was from a center that applied the strategy using brain-dead liver donors (salvage LT strategy center: Henri Mondor University Hospital, Cr eteil, France). (13) (14) (15) The second patient group was from a center that favored the second resection strategy (University of Tokyo Hospital, Tokyo, Japan). (9, 16) Selection criteria of salvage LT (13) (14) (15) and second resection (9, 16) have been previously described by the authors from the 2 centers.
Informed consent was obtained from each patient upon enrollment in the chosen strategy.
After approval from the institutional review board of each institution, data on all consecutive HCC patients who underwent primary liver resection between 1994 and 2011 were retrieved from the prospectively maintained database of each center. The study population included all patients meeting the following criteria:
1. Primary resection had been performed for a resectable and transplantable tumor (see definitions below).
2. Recurrence following primary liver resection was also considered resectable and transplantable and was managed by 1 of these 2 options according to the center strategy.
In both centers, HCC patients were considered resectable when they fulfilled all the following criteria:
1. Absence of prohibitive comorbidities. 2. Normal/acceptable liver function, depending on the potential extent of resection. 3. Planned macroscopic curative (R0) resection. 4. Absence of extrahepatic disease.
The presence of portal hypertension was not considered a strict contraindication for resection. (15, 17) In both centers, preoperative portal vein embolization was used as needed to prepare for major hepatectomy. (18, 19) In addition, in the second resection strategy group, the extent of liver resection was adapted to the results of the indocyanine green (ICG) clearance test. (20) At the second resection strategy center, the indication criteria for second resection were the same as those for primary hepatectomy, and they did not change throughout the study period. (16) HCC patients were considered transplantable when they fulfilled all the following criteria:
1. Absence of prohibitive comorbidities. 2. HCC within the Milan criteria based on preoperative imaging.
Chronological age per se was not a formal contraindication for transplantation.
HCC patients were considered resectable and transplantable when they fulfilled all the above criteria for resection and LT.
Salvage LT was defined as LT performed in patients with HCC recurrence after primary liver resection for resectable and transplantable HCC, provided HCC recurrence was within the Milan criteria and was the primary indication for listing the patient for LT. Patients who underwent LT for the following indications were excluded from the study:
1. LT for tumor recurrence following primary resection for nontransplantable HCC (so-called LT following downstaging primary resection). 2. LT following primary resection and performed before recurrence when decided upon specimen analysis (so-called "de principe" LT) or bridge LT when resection is the chosen neoadjuvant treatment of LT. (21, 22) 3. LT for postresection irreversible liver failure (socalled rescue LT).
Second hepatectomy was defined as a second liver resection in patients with HCC recurrence after a primary liver resection for resectable and transplantable HCC, provided that the HCC recurrence was within the Milan criteria.
Patients designated to undergo salvage LT in the case of resectable and transplantable recurrence constituted the salvage LT strategy group, and those designated to undergo second resection in the same context constituted the second resection strategy group.
Dropouts included those from the salvage LT waiting list and those from aborted second resection before or during surgery.
The salvage LT and second resection strategies were considered completed when patients underwent transplantation or resection for tumor recurrence.
DESIGN OF THE STUDY
In the present study, the relevant analysis was performed to specifically answer the following 3 questions:
1. What are the perioperative and longterm survival outcomes following primary resection of resectable and transplantable HCC? Postoperative course and tumor recurrence were compared in a cohort of 391 patients, including 77 who had a primary resection at the salvage LT strategy center and 314 who had a primary resection at the second resection strategy center. In addition, an intention-to-treat survival analysis including all patients from the time of the primary resection (thus also considering dropouts and patients with no recurrence) was performed. Also, because the 2 populations come from 2 different institutions and are clearly different, a propensity score matching was performed. 2. What was the feasibility of the salvage LT and second resection in HCC patients who had resectable and transplantable tumor recurrence? An evaluation of the actual number and proportion of patients who finally underwent salvage transplantation and second resection when they had recurrence after a primary resection and the reasons for dropout from the 2 strategies was performed. 3. Are the postoperative and longterm outcomes following salvage transplantation and second resection comparable? A comparison of postoperative outcomes and longterm outcomes was performed before and after propensity score matching.
STATISTICAL ANALYSIS
Patient demographics were compared using the v 2 test or Fisher's exact test for categorical variables. Continuous variables were compared using Student t test or the nonparametric Mann-Whitney U test, as appropriate. Survival rates were calculated using the Kaplan-Meier method and compared using the logrank test. Two subsets of patients were analyzed ( Fig. 1 ). An intention-to-treat OS analysis was performed in the whole study population. Intention-to-treat OS was measured from the time of primary liver resection to the last follow-up or the date of death from any cause.
A per-protocol analysis was performed in patients who underwent the second resection or salvage LT. OS was measured from the time of the second surgery, ie, salvage LT or second resection to the last follow-up or the date of death from any cause. Disease-free survival (DFS) was calculated as the total time from the second surgery to recurrence or the last follow-up without recurrence. Patients with no HCC proven by explanted or resected liver specimens were considered not to have tumor recurrence, the main determinant of longterm survival. Those patients were subsequently excluded from the survival analysis.
Propensity score matching complying with the key elements for the valuable use of this methodology (23, 24) was performed in these 2 subsets of patients. All variables included in the propensity score matching were selected a priori on the basis of their potential relationship with survival outcomes. Nearest-neighbor matching without replacement with a caliper size set as 0.2 of the standard deviation of the logit of the estimated propensity score was used.
First, patients who underwent primary resection for initially resectable and transplantable HCC, analyzed on an intention-to treat basis, were matched at a 1:1 ratio. Second, patients who achieved the salvage LT or second resection strategy were matched at a 1:2 ratio after excluding patients without tumor recurrence, ie, postoperative (salvage LT or second resection) death and/or the absence of HCC upon histological examination of a resected or explanted specimen.
Two-tailed P values < 0.05 were considered significant. Statistical analyses were performed using SPSS software, version 22 (IBM SPSS Statistics, Armonk, NY). The present study complies with REporting of studies Conducted using Observational Routinely-collected Data (RECORD) guidelines.
Results
During the study period, 1169 consecutive primary hepatectomies were performed for HCC: 309 (26%) patients at the salvage LT strategy center and 860 (74%) patients at the second resection strategy center.
OUTCOMES FOLLOWING PRIMARY RESECTION

Perioperative Outcomes
As shown in Fig. 1 , the intention-to-treat population (summarized in Table 1 ) comprised 391 patients with resectable and transplantable HCC: 77 (20%) enrolled in the salvage LT strategy center and 314 (80%) patients enrolled in the second resection The 90-day mortality rate following primary resection was 4% (3/77) in the salvage LT strategy group and 0% (0/314) in the second resection strategy group (P 5 0.007).
Recurrence
Recurrence occurred in 49% (36/74 exposed to recurrence) of patients in the salvage LT strategy group and 68% (213/314 exposed to recurrence) of patients in the second resection strategy group (P 5 0.003).
Intention-to-Treat Survival
From the time of primary hepatectomy, the mean follow-up was 69 6 55 months for the salvage LT strategy group (n 5 77) and 67 6 39 months for the second resection strategy group (n 5 314; P 5 0.61).
The intention-to-treat OS was calculated from the time of primary hepatectomy. The intention-to-treat OS rates at 3, 5, and 10 years were 76%, 72%, and 53%, respectively, for the salvage LT strategy group and 90%, 77%, and 53%, respectively, for the second resection strategy group (P 5 0.57; Fig. 2A ). Using propensity score matching to limit the background difference between the 2 populations of patients, 60/77 patients from the salvage LT strategy group could be matched with 60/314 patients from the second resection strategy group. The intention-to-treat OS rates at 3, 5, and, 10 years were 83%, 78%, and 53% in the salvage LT strategy group, respectively, and 94%, 70%, and 54% in the second resection strategy group, respectively (P 5 0.90, Fig. 2B ).
FEASIBILITY OF THE SALVAGE LT AND SECOND RESECTION IN PATIENTS WITH RESECTABLE AND TRANSPLANTABLE TUMOR RECURRENCE
Of the 391 initially resectable and transplantable patients who underwent primary resection, 3 patients died during the postoperative course. Of the remaining 388 patients, 249 had HCC recurrence after primary hepatectomy, including 36 (36/74; 49%) in the salvage NOTE: Continuous variables are expressed as the mean 6 standard deviation and categorical variables as n (%). *At subsegmental level in all cases. † Patients without histologically proven HCC (7 patients) in the rehepatectomy strategy group were excluded from the specimen analysis.
LT strategy group and 213 (213/314; 68%) in the second resection strategy group (P 5 0.003).
Tumor recurrence was deemed resectable and transplantable in 58% (21/36) of patients in the salvage LT strategy group and 38% (81/213) of patients in the second resection strategy group (P 5 0.03). Subsequently, these patients were designated to undergo the planned strategy, ie, 21 for salvage LT and 81 for second resection.
Salvage LT was performed in 18/21 (86%) patients designated for salvage LT, whereas 3 (14%) patients dropped out from the salvage LT waiting list due to tumor progression (n 5 2) or worsening of a cardiovascular comorbidity (n 5 1). There were no dropouts in the group of patients designated to undergo second resection, and this strategy was performed in all 81 (100%) patients. The rate of completed strategy for tumor recurrence was 50% (18/36 patients) in the salvage LT strategy group and 38% (81/213 patients) in the second resection strategy group (P 5 0.20).
OUTCOMES OF PATIENTS WHO ACHIEVED THE SALVAGE LT AND SECOND RESECTION STRATEGY
A detailed comparison of patients who underwent salvage LT and second resection is given in Table 2 . The 90-day mortality rate was 11% (2/18) following salvage LT and 0% (0/81) following second resection (P 5 0.002). The cumulative postoperative mortality rate was 5% (5/95 procedures; 6% [5/77] of patients) for the completed salvage LT strategy, while it was 0% (0/395 procedures; 0/314 patients) for the completed second resection strategy (P < 0.001).
Survival
Two patients (1 in each group) were excluded from the survival analysis because their specimen analysis did not confirm an HCC diagnosis. From the time of the second surgery, the mean follow-up was 70 6 51 months in patients with a completed salvage LT strategy (n 5 17) and 57 6 33 months in patients with a completed second resection strategy (n 5 80; P 5 0.23). The OS was calculated from the time of the second surgery (ie, transplantation or second resection). The OS rates at 3, 5, and 10 years were 71%, 71%, and 45%, respectively, for patients who underwent salvage LT and 82%, 71%, and 46%, respectively, for patients who underwent second resection (P 5 0.99; Fig. 3A ).
Recurrence
Recurrence occurred in 5/17 (29%) patients following salvage LT and 65/80 (81%) patients following second resection (P < 0.0001) within a mean delay period of 53 6 60 and 15 6 17 months, respectively (P 5 0.008). The DFS rates measured from the time of the second surgery at 3, 5, and 10 years were 80%, 72%, and 72%, respectively, following salvage LT and 22%, 18%, and 8%, respectively, following second resection (P < 0.001; Fig. 3B ). NOTE: Continuous variables are expressed as the mean 6 standard deviation and categorical variables as n (%). *At subsegmental level in all cases. † Patients without histologically proven HCC (1 patient in each group) were excluded from the specimen analysis.
FIG. 3. OS and DFS in patients who underwent salvage LT and second resection strategy groups. (A) OS before matching and (B)
DFS before matching.
After Matching
After excluding the 2 patients who did not have HCC as determined by their resected/explanted specimen, 17/17 patients from the salvage LT group could be matched by propensity score matching with 34/80 patients from the second resection group (Table 3) . OS at 3, 5, and 10 years measured from the time of the second surgery (ie, salvage LT or second resection) was similar between patients from the salvage LT and second resection strategy groups (71%, 71%, and 45% versus 71%, 59%, and 52%, respectively; P 5 0.97; Fig. 4A ). NOTE: Continuous variables are expressed as the mean 6 standard deviation and categorical variables as n (%). All tumor variables are from the specimen analysis. *At subsegmental level in all cases.
DFS at 3, 5, and 10 years, measured from the time of the second surgery, was significantly longer in the salvage LT group than in the second resection group (80%, 72%, and 72%, respectively, versus 13%, 13%, and 13%, respectively; P < 0.001; Fig. 4B ).
Discussion
This study should be considered as a first step to assess whether the salvage LT strategy applied for resectable and transplantable tumors at first resection could be renewed for tumor recurrence when both options of second resection and salvage LT are also deemed feasible. Put into this perspective, this is the first study comparing the longterm outcomes of the salvage LT and second resection strategies in patients deemed resectable and transplantable at both the time of primary resection and recurrence.
These strategies achieved similar intention-to-treat OS both when analyzing the entire study population and after matching. (23, 25) Postoperative mortality following primary hepatectomy was significantly lower in the second resection strategy group. This result is no surprise considering the following:
1. This group of patients was managed by a team using a stringent algorithm to select candidates for surgery, with the extent of liver resection being tailored to the functional reserve of the remnant liver according to the results of the ICG clearance test. (26) 2. The known volume-outcome relationship (27) in the field of liver resection (during the study period, the second resection strategy group performed 2.8-fold more primary hepatectomies for HCC than the salvage LT strategy group; Fig. 1 ). 3. The acknowledged perioperative expertise of the second resection strategy group, which reported a mortality rate of 0% at 15 years ago following a series of >1000 hepatectomies performed within an 8-year period. (20) Tumor recurrence following primary resection was significantly more frequent in the second resection strategy group than in the salvage LT strategy group: it cannot be disputed that salvage LT and even primary LT achieve the best DFS. (28) In the present study, both the resectability rate (38%) and the actual transplantability rate (50%) of tumor recurrence compared favorably to the corresponding reported rates. (3, 4, 8, 9) The survival rates following primary hepatectomy, second resection, and salvage LT were comparable to those of other series in the same field. (5, 6, 11, 12) Intention-to-treat OS was similar for the second resection and salvage LT strategy groups (Fig. 2) . This result was obtained despite the second resection strategy group having the following negative characteristics compared with the salvage LT strategy group: a significantly older patient age, a higher proportion of ChildPugh B patients, and more importantly, a significantly higher recurrence rate following not only primary liver resection compared with primary resection in the salvage LT strategy group but also second resection compared with salvage LT. These disadvantages might have been offset by the following:
1. The significantly lower cumulative postoperative mortality rate in the second resection strategy group. 2. The high rate of second resection for the first recurrence (38% in the present series; Fig. 1 ) and its known positive impact on survival. (29) 3. The possibility of a third hepatectomy in 30% of recurrence cases following second resection. (16) 4. The aggressive treatment of nonresectable recurrence cases following second resection, including via the tumor necrosis factor a converting enzyme, local destruction, and sorafenib. (30) (31) (32) The simultaneous application of multiple modalities for recurrent HCC following primary liver resection, rather than the successive application of individual modalities following the failure of the preceding modality, might even improve the results of a second resection. (33) Obviously, DFS following salvage LT was better compared with a second resection due to the following factors:
1. Achieving the safest possible resection margin by total hepatectomy. 2. Resecting clinically undetectable, existing distant micrometastases in the remnant liver. 3. Curing underlying liver disease preventing de novo HCC development in the remaining liver. (28, 34) In addition, this means that patients in the salvage LT group had fewer procedures and treatments and likely had better quality of life than those in the second resection group.
Our study has some limitations, including the retrospective study design. The number of patients who underwent salvage LT was small compared with those who underwent second resection. In addition, after propensity score matching, the size of the 2 groups might be relatively small to detect any difference and to conclude that these 2 groups were well balanced for covariates.
The Asian and Western HCC populations compared here present key differences, particularly in epidemiology and genetics, which might introduce biases. (35) To obviate as much as possible this intrinsic source of biases, only patients with resectable and transplantable HCC submitted to primary resection were included in the intention-to-treat analysis.
However, propensity score matching remains the best way to control these biases as much as possible and does allow comparisons between similar patients with both resectable and transplantable recurrence after primary hepatectomy that were re-treated with 2 curative treatment options (salvage transplantation or second resection) at 2 different institutions. (36) A prospective randomized study comparing the salvage LT and second resection strategies in a homogeneous population and on an intention-to-treat basis would be impossible for obvious practical reasons.
Yet, the decisions to proceed with either strategy are clearly biased by institutional practices. However, there is no easy way to surmount this particular limitation other than comparing 2 different centers. In the current context where liver grafts are scarce, the use of a living donor is risky and given the issue of aging population in HCC, this study should serve as a basis to give data regarding the treatment algorithm and its subsequent outcomes to patients with recurrence after primary resection, and to possibly justify a second resection when this alternative is possible.
Additionally, as in this study, when a management strategy includes 1 or more previous treatment steps, outcomes should be analyzed according to the intention-to-treat principle (25) to limit the biases and confounding factors of OS and DFS, which are typically in this order the main concerns of patients. However, because tumor recurrence and its subsequent management are the main determinants of postsurgery survival (ie, resection or transplantation), previous studies have mainly focused on the risk of recurrence rather than on intention-to-treat OS. (37) (38) (39) Finally, there was no uniform treatment algorithm regarding the use of liver-directed therapy either at initial diagnosis or at time of recurrence. Here again, there is no easy way to limit this bias other than relying in the large sample size and intention-to-treat analysis to limit this confounding factor. Because of various and heterogeneous existing liver-directed therapies, propensity score matching using this variable might be impossible.
In conclusion, the present study, being the first one comparing OS between the salvage LT and second resection strategies on an intention-to-treat basis, showed that these 2 strategies ensure similar 5-year intention-to-treat OS. Salvage LT still achieves better DFS. Although the latter is undisputable, second resection might also be discussed during the shareddecision process between the doctors and the patient for recurrent HCC when both resection and transplantation are deemed feasible.
